Kendall Square CRO — FDA-Aware Pharmaceutical Vocabulary Programme
Client: Phase I-II CRO, Cambridge MA ($18M). Challenge: BMS and Pfizer new VPs Googling — NJ and San Diego CROs appearing. Company invisible despite 18 years of Cambridge clinical expertise. Programme: FDA-aware Phase I-III vocabulary + HMS/Dana-Farber collaboration content + Stat News HARO + FiercePharma editorial + Massachusetts CDPA-compliant analytics Results (12 months): Page 1 for 18 Kendall Square CRO procurement queries | Stat News editorial: 2 | FiercePharma: 3 | BMS new VP digital discovery: achieved | Pipeline from organic: $4.8M
